Entact Bio Revenue and Competitors
Estimated Revenue & Valuation
- Entact Bio's estimated annual revenue is currently $3.5M per year.
- Entact Bio's estimated revenue per employee is $77,500
- Entact Bio's total funding is $121M.
Employee Data
- Entact Bio has 45 Employees.
- Entact Bio grew their employee count by 36% last year.
Entact Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Entact Bio?
Entact Bio is a preclinical stage biotechnology company developing a new class of drugs that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has designed its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs harness the ability of DUBs to regulate proteins. By leveraging this natural cellular mechanism to enhance protein function, Entact is expanding the universe of treatable diseases.
keywords:N/A
$121M
Total Funding
45
Number of Employees
$3.5M
Revenue (est)
36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Watertown
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9M | 45 | 7% | N/A |
#2 | $9M | 45 | 0% | N/A |
#3 | $9.7M | 45 | 0% | N/A |
#4 | $9.3M | 46 | 0% | N/A |
#5 | $12.1M | 46 | 2% | N/A |